Subspecialties

The instinct is to act early to save vision – but at what cost?

Can an anti-VEGF agent outdo PRP for the treatment of PDR?

In patients with glaucoma or thin corneas look to the difference between DCT and GAT.

Topical anti-VEGF therapy may offer AMD patients an alternative to injections.

How to be a more responsible “medical tourist” in seven lessons.

OCT can – and should – be used to support treatment decisions in glaucoma.

Efficient CRISPR gene editing with a newly characterized CjCas9 orthologue.

PDEK’s a compelling keratoplasty option. Here’s how to do it.

“As a pediatric ophthalmologist, it’s my ‘go-to’ ophthalmoscope – I always have one in my pocket!”

"The story has not yet been fully told."